Login to Your Account

Nastech, Questcor File NDA For Spray Form Of Nascobal

By Kim Coghill

Wednesday, December 31, 2003
Questcor Pharmaceuticals Inc. and Nastech Pharmaceutical Co. Inc. filed a new drug application requesting approval of Nascobal Nasal Spray for the treatment of vitamin B-12 deficiency. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription